date:Apr 20, 2023
Royal DSM is entering into negotiations to purchase Adare Biome from its parent company, Adare Pharma Solutions, for an enterprise value of 275 million (US$301.2 million). The move will expand the companys human health and animal nutrition offerings.
DSM states that the acquisition would allow the company to bring some of Adare Biomes signature postbiotic products to the growing gut health and digestive health segments.
Adare Biome would be a perfect fit for DSM, with pioneering science that